Literature DB >> 32095482

Performance of a mixture model by the degree of a missing categorical covariate when estimating clearance in NONMEM.

SeokKyu Yoon1, Hyeong-Seok Lim1.   

Abstract

The accuracy and predictability of mixture models in NONMEM® may change depending on the relative size of inter-individual differences and the size of the differences in the parameters between subpopulations. This study explored the accuracy of mixture models when dealing with missing a categorical covariate under various situations that may occur in reality. We generated simulation data under various scenarios where genotypes representing extensive metabolizers (EM) and poor metabolizers (PM) of drug-metabolizing enzymes affect the clearance of a drug by different degrees, and the inter-individual variations in clearance are different for each scenario. From each simulated datum, a specific proportion of the covariate (genotype information) was randomly removed. Based on these simulation data, the proportion of each individual subpopulation and the clearance were estimated using a mixture model. Overall, the clearance estimate was more accurate when the difference in clearance between subpopulations was large, and the inter-individual variations were small. In some scenarios that showed higher ETA or epsilon shrinkage, the clearance estimates were significantly biased. The mixture model made better predictions for individuals in the EM subpopulation than for individuals in the PM subpopulation. However, the estimated values were not significantly affected by the tested ratio, if the sample size was secured to some extent. The current simulation study suggests that when the coefficient of variation of inter-individual variations of clearance exceeds 40%, the mixture model should be used carefully, and it should be taken into account that shrinkage can bias the results.
Copyright © 2019 Translational and Clinical Pharmacology.

Entities:  

Keywords:  Covariate; Missing categorical; Mixture model; NONMEM

Year:  2019        PMID: 32095482      PMCID: PMC7032962          DOI: 10.12793/tcp.2019.27.4.141

Source DB:  PubMed          Journal:  Transl Clin Pharmacol        ISSN: 2289-0882


  3 in total

1.  Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions.

Authors:  Radojka M Savic; Mats O Karlsson
Journal:  AAPS J       Date:  2009-08-01       Impact factor: 4.009

2.  Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance.

Authors:  Muriel Noetzli; Monia Guidi; Karsten Ebbing; Stephan Eyer; Laurence Wilhelm; Agnès Michon; Valérie Thomazic; Ioana Stancu; Abdel-Messieh Alnawaqil; Christophe Bula; Serge Zumbach; Michel Gaillard; Panteleimon Giannakopoulos; Armin von Gunten; Chantal Csajka; Chin B Eap
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

Review 3.  A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics.

Authors:  C M Blake; E D Kharasch; M Schwab; P Nagele
Journal:  Clin Pharmacol Ther       Date:  2013-05-09       Impact factor: 6.875

  3 in total
  1 in total

1.  Evaluation of the estimation and classification performance of NONMEM when applying mixture model for drug clearance.

Authors:  Ka Ho Hui; Tai Ning Lam
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-10-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.